<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The aim was to analyse the relationship between <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> and type 2 <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo> risk among the aged </plain></SENT>
<SENT sid="1" pm="."><plain>This was a prospective population-based study, with a 9-year follow-up </plain></SENT>
<SENT sid="2" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> subjects of the municipality of Lieto in Finland aged â‰¥64 in 1998-1999 with no type 2 <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo> at baseline (n=1117) were included </plain></SENT>
<SENT sid="3" pm="."><plain>Hazard ratios for incident type 2 <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo> predicted by <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> (defined by modified International <z:mp ids='MP_0002055'>Diabetes</z:mp> Federation criteria) were estimated </plain></SENT>
<SENT sid="4" pm="."><plain>During the 9-year follow-up, a total of 69 participants (6.2%) developed type 2 <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>After multivariable adjustment (age, gender, smoking, frequency of exercise, <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular disease</z:e> and <z:chebi fb="1" ids="47774">low-density lipoprotein-cholesterol</z:chebi>), type 2 <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo> (hazard ratio, 95% confidence interval) (3.15, 1.89-5.25, p &lt; 0.001) was more common in subjects with <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> compared to subjects without it </plain></SENT>
<SENT sid="6" pm="."><plain>Evaluating <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> components individually, impaired fasting <z:chebi fb="105" ids="17234">glucose</z:chebi> (5.09, 2.64-9.82, p &lt; 0.001) and <z:hpo ids='HP_0001513'>obesity</z:hpo> (1.71, 1.05-2.97, p = 0.034) predicted a higher incidence of type 2 <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>Our findings suggest that <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> predicts <z:hpo ids='HP_0003674'>onset</z:hpo> of type 2 <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo> even in late life </plain></SENT>
<SENT sid="8" pm="."><plain>Impaired fasting <z:chebi fb="105" ids="17234">glucose</z:chebi> and <z:hpo ids='HP_0001513'>obesity</z:hpo> should be targets for primary prevention of <z:mp ids='MP_0002055'>diabetes</z:mp> among the aged with <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> </plain></SENT>
</text></document>